Bevacizumab ± irinotecan beneficial for glioblastoma

By  

Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Irinotecan and bevacizumab in recurrent glioblastoma multiforme

By Jakobsen Jan Nyrop   Hasselbalch Benedikte   Stockhausen Marie-Thééréése   Lassen Ulrik   Poulsen Hans Skovgaard  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 825-833

Informa Healthcare

Access to resources Recommend Favorite

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

By Seystahl Katharina   Weller Michael  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 605-617

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

By Strickler John   McCall Shannon   Nixon Andrew   Brady John   Pang Herbert   Rushing Christel   Cohn Allen   Starodub Alexander   Arrowood Christy   Haley Sherri   Meadows Kellen   Morse Michael   Uronis Hope   Blobe Gerard   Hsu S.   Zafar S.   Hurwitz Herbert  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 330-339

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab: Surgical bleeding treated with herbal medicine in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite